SCHEMBL8524586

SCHEMBL8524586

C=CCOC1C[C@@H]2[C@@H](CC[C@]3(C)CCC[C@@H]23)[C@@]2(C)CCC(=O)N(C)C12

nearest known ligand 0.36

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
ATP1A1 P05023 2/20 0.35
ATP1B1 P05026 2/20 0.35
ATP1A3 P13637 2/20 0.35
ATP1B2 P14415 2/20 0.35
ATP1A2 P50993 2/20 0.35
ATP1B3 P54709 2/20 0.35
FXYD2 P54710 2/20 0.35
ATP1A4 Q13733 2/20 0.35
SRD5A1 P18405 5/20 0.34
SRD5A2 P31213 1/20 0.34
CYP19A1 P11511 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4557413 0.80 SRD5A1 (0.32) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL4728085 0.77 CDK5 (0.34) CDK5CDK5R1SRD5A1CYP19A1
SCHEMBL8523978 0.74 HSD17B7 (0.43) SRD5A1SRD5A2CYP19A1
SCHEMBL917618 0.71 SRD5A1 (0.48) SRD5A1SRD5A2
SCHEMBL7802581 0.71 SRD5A1 (0.58) SRD5A1SRD5A2
SCHEMBL7527164 0.71 SRD5A1 (0.58) SRD5A1SRD5A2
SCHEMBL8996745 0.70 SRD5A1 (0.34) SRD5A1SRD5A2
SCHEMBL8996742 0.70 SRD5A1 (0.34) SRD5A1SRD5A2
SCHEMBL8679404 0.68 CYP19A1 (0.39) CDK5CDK5R1SRD5A1SRD5A2CYP19A1
SCHEMBL8075000 0.68 SRD5A1 (0.57) SRD5A1SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0786999-A4 COMBINATION METHOD FOR ACNE TREATMENT MERCK & CO INC (US) 1999-01-20 EP claimed
EP-0786999-A1 COMBINATION METHOD FOR ACNE TREATMENT Merck & Co., Inc. (US) 1997-08-06 EP claimed
WO-1996012487-A1 COMBINATION METHOD FOR ACNE TREATMENT MERCK & CO., INC. (US) 1996-05-02 WO claimed